Long-Term Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients with Cardiac Sarcoidosis

Circulation: Arrhythmia and Electrophysiology

Volumn 9, Issue 8, 2016, Pages

  Muser, Daniele ^a   Santangeli, Pasquale ^a   Pathak, Rajeev K ^a   Castro, Simon A ^a   Liang, Jackson J ^a   Magnani, Silvia ^a   Hayashi, Tatsuya ^a   Garcia, Fermin C ^a   Hutchinson, Mathew D ^a   Supple, Gregory E ^a   Frankel, David S ^a   Riley, Michael P ^a   Lin, David ^a   Schaller, Robert D ^a   Desjardins, Benoit ^a   Dixit, Sanjay ^a   Callans, David J ^a   Zado, Erica S ^a   Marchlinski, Francis E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

catheter ablation; fluorodeoxyglucose F18; positron emission tomography; sarcoidosis, cardiac; tachycardia, ventricular

Indexed keywords

ANTIARRHYTHMIC AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHOTREXATE; PREDNISONE; CONTRAST MEDIUM;

ABLATION CATHETER; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEATH; EPICARDIUM MAPPING; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOIDOSIS; TREATMENT OUTCOME; CARDIOMYOPATHY; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; PROCEDURES; SURVIVAL RATE;

CARDIOMYOPATHIES; CATHETER ABLATION; CONTRAST MEDIA; DIAGNOSTIC IMAGING; EPICARDIAL MAPPING; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84983262185     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.116.004333     Document Type: Article

References (31)

1. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014 11 1305 1323. doi: 10.1016/j.hrthm.2014.03.043
2. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG, Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006 3 924 929. doi: 10.1016/j.hrthm.2006.03.031
3. Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K, Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011 16 140 147. doi: 10.1111/j.1542-474X.2011.00418.x
4. Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, Bogun F, Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 2009 6 189 195. doi: 10.1016/j.hrthm.2008.10.039
5. Paz YE, Bokhari S, The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy. Int J Cardiovasc Imaging 2014 30 431 438. doi: 10.1007/s10554-013-0339-y
6. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 18 1440 1463. doi: 10.1016/j.echo.2005.10.005
7. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM, An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001 218 215 223. doi: 10.1148/radiology.218.1.r01ja50215
8. Rashid S, Rapacchi S, Vaseghi M, Tung R, Shivkumar K, Finn JP, Hu P, Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. Radiology 2014 270 269 274. doi: 10.1148/radiol.13130942
9. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB, Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987 163 697 702. doi: 10.1148/radiology.163.3.3575717
10. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002 105 539 542
11. Bondarenko O, Beek AM, Hofman MB, Kühl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC, Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005 7 481 485
12. Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB, Stevenson WG, Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 2015 8 87 93. doi: 10.1161/CIRCEP.114.002145
13. Paquet N, Albert A, Foidart J, Hustinx R, Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med 2004 45 784 788
14. Callans DJ, Ren JF, Michele J, Marchlinski FE, Dillon SM, Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis. Circulation 1999 100 1744 1750
15. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E, Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000 101 1288 1296
16. Cano O, Hutchinson M, Lin D, Garcia F, Zado E, Bala R, Riley M, Cooper J, Dixit S, Gerstenfeld E, Callans D, Marchlinski FE, Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol 2009 54 799 808. doi: 10.1016/j.jacc.2009.05.032
17. Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC, Dixit S, Lin D, Tzou WS, Cooper JM, Verdino RJ, Callans DJ, Marchlinski FE, Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2011 4 49 55. doi: 10.1161/CIRCEP.110.959957
18. Sosa E, Scanavacca M, d'Avila A, Pilleggi F, A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996 7 531 536
19. Hsia HH, Lin D, Sauer WH, Callans DJ, Marchlinski FE, Relationship of late potentials to the ventricular tachycardia circuit defined by entrainment. J Interv Card Electrophysiol 2009 26 21 29. doi: 10.1007/s10840-009-9421-8
20. Bogun F, Krishnan SC, Marine JE, Hohnloser SH, Schuger C, Oral H, Pelosi F, Chugh A, Morady F, Catheter ablation guided by termination of postinfarction ventricular tachycardia by pacing with nonglobal capture. Heart Rhythm 2004 1 422 426. doi: 10.1016/j.hrthm.2004.06.009
21. Desjardins B, Morady F, Bogun F, Effect of epicardial fat on electroanatomical mapping and epicardial catheter ablation. J Am Coll Cardiol 2010 56 1320 1327. doi: 10.1016/j.jacc.2010.04.054
22. Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, Vergara P, Bisceglia C, Santagostino G, Marzi A, Sora N, Roque C, Guarracini F, Tsiachris D, Radinovic A, Cireddu M, Sala S, Gulletta S, Paglino G, Mazzone P, Trevisi N, Della Bella P, Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol 2014 7 414 423. doi: 10.1161/CIRCEP.114.001568
23. Dechering DG, Kochhäuser S, Wasmer K, Zellerhoff S, Pott C, Köbe J, Spieker T, Piers SR, Bittner A, Mönnig G, Breithardt G, Wichter T, Zeppenfeld K, Eckardt L, Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2013 10 158 164. doi: 10.1016/j.hrthm.2012.10.019
24. Naruse Y, Sekiguchi Y, Nogami A, Okada H, Yamauchi Y, Machino T, Kuroki K, Ito Y, Yamasaki H, Igarashi M, Tada H, Nitta J, Xu D, Sato A, Aonuma K, Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol 2014 7 407 413. doi: 10.1161/CIRCEP.113.000734
25. Santangeli P, Zado ES, Supple GE, Haqqani HM, Garcia FC, Tschabrunn CM, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley MP, Marchlinski FE, Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2015 8 1413 1421. doi: 10.1161/CIRCEP.115.003562
26. Tzou WS, Frankel DS, Hegeman T, Supple GE, Garcia FC, Santangeli P, Katz DF, Sauer WH, Marchlinski FE, Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythm Electrophysiol 2015 8 353 361. doi: 10.1161/CIRCEP.114.002310
27. Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE, Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 2006 135 68 75. doi: 10.1016/j.jss.2006.03.024
28. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, Gomes JA, Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991 18 937 943
29. Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y, Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004 27 217 222
30. Hiramitsu S, Morimoto S, Uemura A, Kato Y, Kimura K, Ohtsuki M, Kato S, Sugiura A, Miyagishima K, Hishida H, Sugisaki K, Tsuda T, National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 210 213
31. Orii M, Hirata K, Tanimoto T, Ota S, Shiono Y, Yamano T, Matsuo Y, Ino Y, Yamaguchi T, Kubo T, Tanaka A, Akasaka T, Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block. Heart Rhythm Off J Heart Rhythm Soc 2015 12 2477 2485. doi: 10.1016/j.hrthm.2015.06.032